Azelaic Acid

Also known as: Nonanedioic acid · Skinoren (brand name) · Azclear (brand name) · Finacea (brand name) · Dicarboxylic acid (chemical class)

Aesthetics

Definition

Azelaic Acid is a naturally occurring saturated dicarboxylic acid (with the chemical formula $C_9H_{16}O_4$) that has gained widespread clinical significance in dermatology and aesthetic medicine. Primarily derived from cereal grains such as wheat, rye, and barley, or produced synthetically for commercial formulations, it functions as a multi-action topical therapeutic agent. It is widely prescribed for the treatment of acne vulgaris, inflammatory rosacea, and various forms of hyperpigmentation, including melasma and post-inflammatory hyperpigmentation (PIH). (PDS)

In the context of Philippine dermatology, Azelaic Acid is recognized by the Food and Drug Administration (FDA) of the Philippines as a regulated pharmaceutical ingredient at high concentrations (typically 15% and 20%) and as a permitted cosmetic ingredient at lower concentrations (typically 10% or less). Its primary pharmacological mechanisms include the selective inhibition of hyperactive melanocytes through the inhibition of the enzyme tyrosinase, reduction of follicular keratinization, and broad-spectrum anti-inflammatory and antibacterial activity against Cutibacterium acnes. (FDA)

Identities

Source Type	Identity
Wikipedia	Azelaic acid
Wikidata	Q413629
DBpedia	Azelaic_acid
ProductOntology	N/A
Wiktionary	azelaic acid
Library of Congress Subject Headings (LCSH)	Dermatologic agents — Therapeutic use — Philippines
MeSH	D000072396
NCBI Taxonomy	N/A
AGROVOC	c_898
Google Scholar	Azelaic acid acne melasma efficacy Philippines
ConceptNet	azelaic_acid
OpenCyc	N/A

Also Known As

Nonanedioic acid
Skinoren (brand name)
Azclear (brand name)
Finacea (brand name)
Dicarboxylic acid (chemical class)

Geography and Climate

The therapeutic utility of Azelaic Acid is highly relevant to the geographic and climatic conditions of the Philippines. As an equatorial archipelago, the country experiences a hot, humid tropical climate year-round, characterized by high temperatures and elevated relative humidity. These climatic conditions stimulate the sebaceous glands, leading to increased sebum production, clogged pores, and a higher prevalence of acne vulgaris and inflammatory skin diseases among the population. (PDS)

Furthermore, the intense ultraviolet (UV) radiation prevalent in the tropical climate of the Philippines acts as a major trigger for pigmentary disorders such as melasma and post-inflammatory hyperpigmentation. Unlike other aggressive skin-lightening agents like hydroquinone or topical retinoids, which can cause severe photosensitivity and irritation when exposed to tropical sunlight, Azelaic Acid is non-photosensitizing. This makes it an ideal, year-round dermatological option for patients residing in warm climates, provided it is paired with daily broad-spectrum sunscreen application to prevent UV-induced melanogenesis.

Demographics

The demographics of individuals utilizing Azelaic Acid in the Philippines span a wide range of age groups and socioeconomic classes. The primary consumer base consists of teenagers and young adults aged 15 to 30, who frequently seek treatment for active acne vulgaris and subsequent post-acne scarring. Due to the high prevalence of Fitzpatrick skin types IV and V in the Philippine population, post-inflammatory hyperpigmentation is a common and distressing sequel to acne, making Azelaic Acid a popular choice for its dual-action treatment of inflammation and dark spots.

Additionally, adult women aged 30 to 50 represent a significant demographic, particularly those suffering from melasma or rosacea. While rosacea is historically associated with lighter skin types, erythematotelangiectatic and papulopustular rosacea are increasingly diagnosed in the Philippines, with patients seeking Azelaic Acid to manage vascular hyperreactivity and skin redness. The product is utilized across urban centers like Metro Manila, Metro Cebu, and Metro Davao, where aesthetic awareness and access to board-certified dermatologists are highest.

Economy and Industry

The market for Azelaic Acid in the Philippines forms a vital segment of the broader dermatological and cosmetic skincare industry. Valued at millions of pesos annually, this market includes prescription-grade topical treatments, over-the-counter (OTC) formulations, and consumer-grade skincare cosmetics. Global pharmaceutical companies import major brand-name formulations, such as Skinoren (manufactured by LEO Pharma), which are distributed through major national drugstore chains such as Mercury Drug and Watsons. (Watsons)

In recent years, the local aesthetic industry has witnessed a surge in compounding pharmacies and homegrown Filipino skincare brands offering lower-concentration (10%) Azelaic Acid serums and creams. This domestic production has democratized access to the ingredient, making it available to middle-income consumers who seek affordable skincare routines. The rise of e-commerce platforms like Lazada and Shopee has further accelerated the distribution of these local skincare products, creating a robust digital retail ecosystem for active ingredients.

Transportation and Infrastructure

The physical distribution of Azelaic Acid products throughout the Philippines relies on a structured pharmaceutical supply chain. Imported products arrive at major ports of entry, primarily the Port of Manila, and are transferred to climate-controlled warehouses. Because topical emulsions, gels, and creams containing Azelaic Acid are sensitive to extreme heat, logistics companies must utilize temperature-controlled transport vehicles to prevent phase separation and active ingredient degradation during transit across the islands.

The digital infrastructure supporting the prescription of Azelaic Acid has expanded rapidly, particularly following the rise of telemedicine during the COVID-19 pandemic. Telehealth platforms and online pharmacy networks allow patients in remote provinces to consult with Manila-based board-certified dermatologists, receive electronic prescriptions, and have specialized Azelaic Acid formulations delivered directly to their doorsteps, bridging the gap in rural healthcare access.

Culture and Tourism

In Philippine society, skin health is deeply intertwined with cultural concepts of beauty, cleanliness, and social mobility. The local beauty market places a high premium on a clear, even complexion, often referred to as the “glass skin” aesthetic, which is heavily influenced by South Korean and Western media. Consequently, products that target acne blemishes and dark spots, such as Azelaic Acid, enjoy high cultural acceptance and demand.

The wellness and medical tourism sector in the Philippines also utilizes Azelaic Acid as part of post-procedure care. International tourists visiting high-end aesthetic clinics in Makati, Bonifacio Global City, and Cebu for laser resurfacing or chemical peels are frequently prescribed Azelaic Acid to manage post-inflammatory hyperpigmentation, ensuring a safe recovery under the tropical sun.

Government and Administration

The regulation and distribution of Azelaic Acid are strictly overseen by the Food and Drug Administration (FDA) of the Philippines under the Department of Health (DOH). The FDA classifies topical products containing 15% and 20% Azelaic Acid as prescription-only medicines (Rx), requiring a licensed physician’s prescription for purchase. This regulation is designed to prevent misuse, as high-concentration formulations can cause skin barrier compromise if applied incorrectly. (FDA)

For the cosmetics industry, the FDA permits the inclusion of Azelaic Acid in over-the-counter skincare products, provided the concentration does not exceed established safety thresholds (typically up to 10%) and the product does not make therapeutic claims, such as curing clinical acne or rosacea. The agency conducts regular market surveillance and issues public advisories against unregistered cosmetic products containing undisclosed or illegal levels of active dermatological drugs.

Education and Healthcare

Dermatological education in the Philippines ensures that healthcare providers are thoroughly trained in the clinical application of Azelaic Acid. The Philippine Dermatological Society (PDS), the only specialty society in dermatology recognized by the Philippine Medical Association (PMA), incorporates the pharmacology and therapeutic guidelines of Azelaic Acid into its residency training programs across accredited institutions. (PDS)

In the public health sector, primary care physicians in community health centers are educated on identifying acne and rosacea, allowing them to refer severe cases to specialists or prescribe entry-level topical treatments. Public health education campaigns also focus on teaching consumers the difference between cosmetic-grade skin care and prescription-grade treatments, promoting safe self-care practices.

Examples and Analogies

To understand the mechanism of Azelaic Acid, one can compare it to a selective security team at a high-profile venue. Unlike harsh chemical treatments that act like a broad-spectrum clearing crew—removing both friendly guests and troublemakers (which represents how hydroquinone or strong acids can irritate both normal and hyperactive skin cells)—Azelaic Acid is highly selective. It identifies only the “hyperactive” or abnormal pigment-producing cells (melanocytes) and gently restricts their activity, while leaving healthy, normal pigment cells to function without interference.

Another analogy is that of a gentle street sweeper. Instead of scraping the asphalt away (like aggressive physical scrubs or strong chemical peels), Azelaic Acid slowly and steadily sweeps away the debris of dead skin cells that clog the pores (keratinocytes) and reduces the bacterial population (Cutibacterium acnes) causing blockages. It performs this maintenance quietly and consistently, preventing structural blockages (microcomedones) without destabilizing the surrounding road infrastructure (the skin barrier).

Usage Scenarios

Scenario 1: Managing Acne and PIH in a Humid Environment

A 22-year-old female university student in Manila suffers from persistent papulopustular acne exacerbated by daily commuting in hot, humid, and polluted conditions. Her dermatologist prescribes a 15% Azelaic Acid gel to be applied twice daily, combined with a gentle cleanser and a non-comedogenic sunscreen. Within eight weeks, her active inflammatory lesions subside, and the dark spots left behind by previous acne breakouts begin to fade significantly.

Scenario 2: Addressing Melasma in a Mature Patient

A 45-year-old female outdoor market vendor in Iloilo notices symmetrical brown patches developing on her cheeks and forehead due to chronic sun exposure. A board-certified dermatologist diagnoses her with melasma and prescribes a 20% Azelaic Acid cream as an alternative to hydroquinone, which the patient cannot tolerate due to contact dermatitis. The treatment successfully lightens the patches over several months without causing skin irritation.

Strategies

Gradual Integration: Start applying Azelaic Acid every other night for the first two weeks to allow the skin barrier to adapt, before increasing to daily or twice-daily application.
The Sandwich Method: Apply a thin layer of moisturizer before and after applying Azelaic Acid to minimize the temporary itching or tingling sensation often experienced by new users.
Synergistic Combination: Pair Azelaic Acid with other barrier-supporting ingredients, such as niacinamide or hyaluronic acid, to enhance hydration and reduce potential dryness.
Daily Sun Protection: Always apply a broad-spectrum sunscreen with SPF 30 or higher during the day, as UV exposure will counteract the pigment-correcting benefits of the acid.

Security and Safety Measures

Perform a Patch Test: Apply a small amount of the product to the inner forearm or jawline for 48 hours to check for allergic reactions or severe irritation before facial application.
Avoid Sensitive Areas: Keep the product away from the immediate eye area, mucosal membranes, and corners of the mouth to prevent severe burning sensations.
Monitor the Skin Barrier: If persistent redness, peeling, or a burning sensation occurs, reduce the frequency of application or discontinue use and consult a physician.
Verify Product Authenticity: Only purchase prescription-strength Azelaic Acid from licensed, reputable pharmacies to avoid counterfeit products contaminated with heavy metals or steroids.

Historical Context

The development of Azelaic Acid as a dermatological treatment began in the late 1970s and early 1980s when researchers investigating the yeast Malassezia furfur (responsible for tinea versicolor) discovered that the dicarboxylic acids it produced were capable of inhibiting melanogenesis. This discovery led to the synthesis of Azelaic Acid for clinical trials, resulting in its approval for acne treatment in Europe and the United States in the late 1980s and 1990s.

In the Philippines, Azelaic Acid gained mainstream popularity in the early 2000s with the introduction of Skinoren. Over the subsequent two decades, as dermatologists sought safer long-term alternatives to hydroquinone—which was restricted due to risks of exogenous ochronosis—Azelaic Acid became a cornerstone of hyperpigmentation therapy in the country.

Challenges and Controversies

The Tingling Sensation and Patient Compliance

A primary challenge in Azelaic Acid therapy is the transient itching, tingling, or burning sensation that occurs immediately after application. Although this is a common, non-harmful side effect that typically subsides within a few weeks, it frequently leads to premature discontinuation of the treatment by patients who mistake it for an allergic reaction.

Cosmetic Mislabeling and Illegal Concentrations

The cosmetic industry faces ongoing controversy regarding the illegal marketing of products containing high concentrations of Azelaic Acid as cosmetic serums. Unscrupulous online manufacturers sometimes bypass FDA registration, selling 20% formulations without medical oversight, which increases the risk of skin barrier damage among consumers.